Medtronic plc (NYSE:MDT), the global leader in medical technology, recently announced that Sugar.IQ with Watson, the first-of-its-kind cognitive app that helps detect important patterns and trends for ...

Two years after originally announcing it, Medtronic and IBM Watson have launched their joint platform the Sugar.IQ, a digital diabetes assistant. “It is designed for people who are currently using ...

Medical device major Medtronic plcMDT recently announced the first human use of its latest Sugar.IQ with Watson app. The application has been developed in collaboration with Watson Health, a division ...

Medtronic came out with two pieces of news yesterday around its connected diabetes efforts: an FDA clearance for a hybrid closed loop insulin delivery system and the first test cohort of its Sugar.IQ ...